LQDA (Liquidia) Tariff Resilience Score: 6/10 (As of Jul. 03, 2026)


LQDA Liquidia Corp LQDA
67 GF Score
Price $78.94
GF Value $224.65
Valuation Possible Value Trap
! 6 Warning Signs
View Full Analysis

What is Liquidia Tariff Resilience Score?

Liquidia LQDA -0.44% 67 Tariff Resilience Score is 6 as of Jul. 03, 2026. GuruFocus rates LQDA with a GF Score™ of 67/100 and a GF Value™ of $224.65 (Possible Value Trap). The stock has 6 warning signs investors should review. Among 1,030 Drug Manufacturers companies, Liquidia ranks better than 91.17% on this metric.

Liquidia has the Tariff Resilience Score of 6, which implies that the company might have Average Resilient.

Liquidia has Pharmaceutical company with moderate exposure to tariffs on raw materials. Focus on innovative drug delivery systems and potential for alternative sourcing provide some resilience.

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes Liquidia might have Average Resilient.

Liquidia  (NAS:LQDA) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score Resilience Level
7 - 10Highly Resilient
4 - 6Average Resilient
0 - 3Highly Vulnerable

Liquidia Tariff Resilience Score Related Terms

LQDA vs LNTH, HIMS, AMRX: Tariff Resilience Score Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Liquidia's Tariff Resilience Score, along with its competitors' market caps and Tariff Resilience Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Liquidia Tariff Resilience Score vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Liquidia's Tariff Resilience Score distribution charts can be found below:

* The bar in red indicates where Liquidia's Tariff Resilience Score falls into.


LQDA
67GF Score
Liquidia Corp LQDA
Tariff Resilience Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Tariff Resilience Score of 6 mean?
Liquidia (LQDA) has a Tariff Resilience Score of 6 as of Jul. 03, 2026. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. According to the industry distribution chart, Liquidia ranks #91 out of 1030 companies in the Drug Manufacturers industry, placing it in the top 8.8%.
Is Liquidia's Tariff Resilience Score too high?
Liquidia's current Tariff Resilience Score is 6. Based on the distribution chart, Liquidia ranks #91 out of 1030 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Liquidia has a GF Score™ of 67/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Liquidia's Tariff Resilience Score compare to LNTH and HIMS?
According to the Drug Manufacturers industry distribution chart, Liquidia ranks #91 out of 1030 companies for Tariff Resilience Score. This places Liquidia in the top 9% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Tariff Resilience Score for a Drug Manufacturers company?
A good Tariff Resilience Score depends on the Drug Manufacturers industry context. However, Tariff Resilience Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Tariff Resilience Score mean?
A high Tariff Resilience Score can signal that a stock is expensive relative to its fundamentals. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. Liquidia's current Tariff Resilience Score is 6. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Liquidia stock overvalued right now?
Based on GuruFocus' analysis, Liquidia (LQDA) is currently considered Possible Value Trap. The stock's GF Value™ is $224.65, compared to a current price of $78.94 — trading 64.9% below its estimated fair value. The current Tariff Resilience Score is 6. Liquidia's overall GF Score™ is 67/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Tariff Resilience Score calculated?
Tariff Resilience Score is calculated from a company's financial statements. For Liquidia (LQDA), the current Tariff Resilience Score is 6 as of Jul. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Liquidia (LQDA) Overvalued in 2026?

Based on GuruFocus' analysis, Liquidia stock appears to be undervalued. The current stock price of $78.94 is trading 64.9% below its estimated GF Value™ of $224.65. GuruFocus considers Liquidia to be Possible Value Trap.

Key valuation signals for LQDA:

  • Tariff Resilience Score: 6
  • GF Value™: $224.65 vs. price of $78.94 (64.9% below fair value)
  • GF Score™: 67/100 with 6 warning signs

No single metric tells the full story. See the LQDA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Liquidia Business Description

Other Exchanges LT4:Germany
Address 419 Davis Drive, Suite 100, Morrisville, NC, USA, 27560
Liquidia Corp is a United States-based biopharmaceutical company focused on the development, manufacturing, and commercialization of products that address unmet patient needs, with the current focus directed towards the treatment of pulmonary hypertension (PH) and pulmonary hypertension associated with interstitial lung disease. It conducts research, development, and manufacturing of novel products by applying its proprietary PRINT technology, a particle engineering platform, to enable the precise production of uniform drug particles. Its product includes YUTREPIA (treprostinil) inhalation powder, for the treatment of pulmonary arterial hypertension. The company also conducting studies on L606, an investigational, liposomal formulation of treprostinil.
67GF Score

Get the complete analysis for LQDA

Tariff Resilience Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$78.94
Price
$224.65
GF Value